182
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Meibomian Gland Alterations in Polycystic Ovary Syndrome

, , , , , , & show all
Pages 133-138 | Received 26 Jul 2007, Accepted 10 Dec 2007, Published online: 02 Jul 2009

REFERENCES

  • Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745–2749
  • Michelmore K F, Balen A H, Dunger D B, Vessey M B. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999; 51: 779–786
  • Diamanti-Kandarakis E, Kouli C R, Bergiele A T, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006–4011
  • Asuncion M, Calvo R M, Millan J LS, Sancho J, Avila S, Escobar-Morreale H F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434–2438
  • Nestler J E, Powers L P, Matt D W, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72: 83–89
  • Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001; 45: 211–220
  • McCulley J P, Shine W E. The lipid layer of tears: Dependent on meibomian gland function. Exp Eye Res. 2004; 78: 361–365
  • Sutphin J E, Chodosh J, Dana M R, . Normal physiology of the ocular surface. Basic and Clinical Science Course External Disease and Cornea, T J Liesegang, G L Skuta, L B Cantor, et al. American Academy of Ophthalmology, San Francisco 2005; 47–52
  • Sullivan D A, Sullivan B D, Ullman M D, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000; 41: 3732–3742
  • Bron A J, Tiffany J M. The meibomian glands and tear film lipids. Advances in Experimental Medicine and Biology: Lacrimal Gland, Tear film, and Dry Eye Syndromes. 2. Basic Science and Clinical Relevance, D A Sullivan, D A Dartt, M A Meneray. Plenum, New York 1998; 281–295
  • Krenzer K L, Dana M R, Ullman M D, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000; 85: 4874–4882
  • Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril. 2004; 81: 361–366
  • Bonini S, Mantelli F, Moretti C, Lambiase A, Bonini S, Micera A. Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol 2007; 143: 763–771
  • Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440–1447
  • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
  • Lin P Y, Cheng C Y, Hsu W M, et al. Association between symptoms and elderly Chinese population in Taiwan: The Shihpai Eye Study. Invest Ophthalmol Vis Sci 2005; 46: 1593–1598
  • van Bijsterveld O P. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969; 82: 10–14
  • Nelson J D, Wright J C. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984; 102: 1049–1052
  • Kari O, Aho V V, Peltonen S, et al. Group I IA phospholipase A(2) concentration of tears in patients with ocular rosacea. Acta Ophthalmol Scand. 2005; 83: 483–486
  • Schein O D, Tielsch J M, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population based perspective. Ophthalmology 1997; 104: 1395–1401
  • Diamanti-Kandarakis E, Papavassiliou A G. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006; 12: 324–332
  • Alves M, Cunha D A, Calegari V C, et al. Nuclear factor-kappa B and advanced glycation end-products expression in lacrimal glands of aging rats. J Endocrinol. 2005; 187: 159–166
  • Alves M, Calegari V C, Cunha D A, Saad M J, Velloso L A, Rocha E M. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. Diabetologia. 2005; 48: 2675–2681
  • Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ohthalmol 1995; 113: 1266–1270
  • Rocha E M, Wickham L A, da Silveira L A, et al. Identification of androgen receptor protein and 5-alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000; 84: 76–84
  • Sullivan D A, Sullivan B D, Evans J E, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann NY Acad Sci 2002; 966: 211–222
  • Erdem U, Ozdegirmenci O, Sobacı E, Sobaci G, Göktolga U, Dagli S. Dry eye in post-menopausal women using hormone replacement therapy. Maturitas, doi:10.1016/j.maturitas.2006.08. 007
  • Schirra F, Richards S M, Liu M, Suzuki T, Yamagami H, Sullivan D A. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res 2006; 83: 291–296
  • Mathers W D, Stovall D, Lane J A, Zimmerman M B, Johnson S. Menopause and tear function: The influence of prolactin and sex hormones on human tear production. Cornea. 1998; 17: 353–358
  • Labrie F, Bélanger A, Luu-The V, (1999) Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues. Proceedings of the Workshop on DHEA: A Comprehensive Review, Amsterdam, 1997, J HH Thijssen, H Nieuwenhuyse, et al. Parthenon Publishing, New York, 69–103
  • Fassnacht M, Schlenz N, Schneider S B, Wudy S A, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2760–2766
  • Schirra F, Suzuki T, Dickinson D P, Townsend D J, Gipson I K, Sullivan D A. Identificantion of steroidogenic enzyme mRNAs in the human lacrimal gland, meibomian gland, cornea, and conjunctiva. Cornea 2006; 25: 438–442

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.